Khoso Baluch's Insider Trades & SAST Disclosures
Khoso Baluch's most recent trade in Longeveron Inc - Ordinary Shares - Class A was a trade of 1,250 Class A Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Dec. 2, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Khoso Baluch.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 02 Dec 2024 | 1,250 | 23,750 | - | 2.1 | 2,588 | Class A Common Stock |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 31,206 | 31,206 | - | - | Restricted Stock | |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 38,375 | - | 0 | Class A Common Stock | |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 09 Jun 2024 | 125 | 14,875 | - | 1.1 | 133 | Common Stock |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 28 Dec 2023 | 8,322 | 15,000 | - | 1.4 | 11,915 | Common Stock |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 28 Dec 2023 | 1,678 | 6,678 | - | 1.4 | 2,342 | Common Stock |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 101,365 | 101,365 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 15,455 | 0 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 15,455 | 27,955 | - | - | Common Stock | |
| Longeveron Inc - Ordinary ... | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.80 per share. | 09 Feb 2023 | 12,500 | 12,500 | - | 0.8 | 10,000 | Common Stock |
| Processa Pharmaceuticals Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 19,091 | 19,091 | - | - | Restricted Stock | |
| CorMedix Inc | Khoso Baluch | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Khoso Baluch | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 13 Aug 2020 | 4,830 | 60,905 (0%) | 0% | 4.1 | 19,985 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges